Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
KOTRA Hosts Briefing on U.S., EU, and Global South Regulatory Responses
1+ day, 4+ hour ago (125+ words) Published 13 Sep.2026 11:11(KST) On the 11th, at the headquarters, KOTRA held the "Global Trade and Certification Environment Changes and Corporate Response Strategy Briefing," where Kim Seongsu, Head of Export Field Support at KOTRA, delivered the opening remarks. KOTRA The Korea Trade-Investment…...
New LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market
5+ day, 16+ hour ago (334+ words) Sep 08, 2026, 09:28 ET Global biotech start-ups and affiliated partner organizations will have access to the Boston and Cambridge ecosystem in Kendall Square to forge cross-border collaboration through networking, education, and programming BOSTON, Sept. 8, 2026 /PRNewswire/ -- LabCentral recently announced the launch of The…...
Mint Venture Partners Lists Three Biotech Bets on KOSDAQ
1+ week, 3+ day ago (283+ words) Organoid Sciences, Aimed Bio and Mezoo Complete Listings Firm Recoups Principal and Target Return Five Years After First Blind Fund Portfolio Spans 17 Domestic and 10 Overseas Companies Two New Funds in the Works as Medical Innovation Bets Expand Mint Venture Partners,…...
Biotron Limited Showcases Diverse Drug Pipeline and Upcoming Milestones at Melbourne Biotech Event
1+ week, 4+ day ago (100+ words) What Is Keeping Alcoa (ASX:AAI) in Technical Analysis Focus? Why Is Champion Iron (ASX:CIA) in the Technical Analysis Spotlight? What Could Keep Pantoro Gold (ASX:PNR) in Technical Analysis Focus? Why Could Iress (ASX:IRE) Enter the Technology…...
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
1+ week, 4+ day ago (279+ words) Alteogen grants Novartis options to develop subcutaneous formulations using its ALT-B4 hyaluronidase platform, NewBiologix and Synastra partner to develop a stable producer cell line, and RedHill acquires global commercialization rights to Ferring's Rebyota and Clenpiq. Alteogen Inc. entered into an…...
Vitrafy Life Sciences Partners with Charter Medical to Enter U.S. Cell and Gene Therapy Market
1+ week, 5+ day ago (71+ words) Kalkine Media What Is Keeping Zip Co (ASX:ZIP) in Focus Among Technology Stocks? Vitrafy Life Sciences Limited (ASX:VFY) VFY (ASX:VFY) has secured a partnership with Charter Medical, LLC to implement its cryopreservation ecosystem at Charter Medical's Innovation…...
Deals in brief: Bioactivx raises pre-Series A funding, SMBC and Singtel Innov8 back fileAI, latest China investments, and more
1+ week, 6+ day ago (499+ words) The latest round brings Bioactivx’s total funding to USD 4.9 million. Bioactivx will use the funding to expand its manufacturing capabilities in Singapore and strengthen its commercial and regulatory teams. It also plans to support post-market clinical trials and advance its…...
Aplus Biotechnology Poised for Stronger Second Half, Targets 20% Annual Growth in Overseas Markets — BigGo Finance
2+ week, 4+ day ago (216+ words) In the Vietnam market, shipments resumed in the first half after certification renewals were completed, helping to fill the previous supply gap and serving as a key driver behind July's record monthly revenue. The China market, benefiting from product mix…...
Licensing Roundup: Biohaven & SK Biopharmaceuticals Enter Deal for BHV-7000, Haisco License???s Sentivera Lead Immunology Asset
2+ week, 4+ day ago (251+ words) Biohaven grants SK Biopharmaceuticals an exclusive worldwide license to its Kv7 ion channel platform, while Haisco licenses a preclinical type 2 inflammatory disease asset to newly formed Sentivera. Two licensing agreements this week show biotech companies turning to partnerships and Newco structures…...
BIOA_B: Leqembi's subcutaneous launch and new partnerships drive growth, with strong financials supporting R&D
2+ week, 4+ day ago (81+ words) TradingView BIOA_B: Leqembi's subcutaneous launch and new partnerships drive growth, with strong financials supporting R&D Leqembi achieved FDA approval and U.S. launch for its subcutaneous formulation, driving global sales growth and expanding patient access. Strategic partnerships with Eli Lilly and Mesenkia…...